Fresenius Medical Care AG

BATS-CHIXE:FMED Stock Report

Market Cap: €12.5b

Fresenius Medical Care Future Growth

Future criteria checks 3/6

Fresenius Medical Care is forecast to grow earnings and revenue by 19.3% and 3.8% per annum respectively. EPS is expected to grow by 18% per annum. Return on equity is forecast to be 7.7% in 3 years.

Key information

19.3%

Earnings growth rate

18.0%

EPS growth rate

Healthcare earnings growth23.3%
Revenue growth rate3.8%
Future return on equity7.7%
Analyst coverage

Good

Last updated18 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BATS-CHIXE:FMED - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202620,6321,1031,8782,71316
12/31/202519,8709371,9562,56218
12/31/202419,2576781,7832,57218
9/30/202419,2396591,5382,274N/A
6/30/202419,4155301,3422,049N/A
3/31/202419,4744841,9112,613N/A
12/31/202319,4544991,9182,629N/A
9/30/202319,4634501,7992,509N/A
6/30/202319,6225961,6742,407N/A
3/31/202319,5546021,4012,152N/A
12/31/202219,3986731,3972,167N/A
9/30/202219,0487631,4442,237N/A
6/30/202218,3938061,4442,271N/A
3/31/202217,9578781,5762,441N/A
12/31/202117,6199691,6032,489N/A
9/30/202117,3729181,4772,405N/A
6/30/202117,3449981,4802,459N/A
3/31/202117,5811,1312,8693,857N/A
12/31/202017,8591,1643,1484,233N/A
9/30/202018,0391,3303,2994,420N/A
6/30/202018,0441,3093,3774,542N/A
3/31/202017,8321,2121,8323,075N/A
12/31/201917,4771,2001,4042,567N/A
9/30/201917,1961,2821,3672,494N/A
6/30/201916,8351,2341,2462,379N/A
3/31/201916,7041,9741,0652,182N/A
12/31/201816,5471,9829202,062N/A
9/30/201816,6761,9517661,892N/A
6/30/201816,9541,975N/A1,750N/A
3/31/201817,2111,250N/A1,977N/A
12/31/201717,7841,280N/A2,192N/A
9/30/201717,7711,249N/A2,436N/A
6/30/201717,6471,244N/A2,217N/A
3/31/201717,2011,239N/A1,938N/A
12/31/201616,5701,144N/A1,932N/A
9/30/201616,1011,063N/A1,648N/A
6/30/201615,841998N/A1,782N/A
3/31/201615,402933N/A1,491N/A
12/31/201515,455955N/A1,767N/A
9/30/201515,345939N/A1,791N/A
6/30/201515,246948N/A1,914N/A
3/31/201515,428977N/A2,044N/A
12/31/201413,329864N/A1,538N/A
9/30/201412,413839N/A1,476N/A
6/30/201411,112775N/A1,283N/A
3/31/201410,882791N/A1,329N/A
12/31/201310,816806N/A1,478N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: FMED's forecast earnings growth (19.3% per year) is above the savings rate (2.1%).

Earnings vs Market: FMED's earnings (19.3% per year) are forecast to grow faster than the UK market (14.8% per year).

High Growth Earnings: FMED's earnings are forecast to grow, but not significantly.

Revenue vs Market: FMED's revenue (3.8% per year) is forecast to grow faster than the UK market (3.5% per year).

High Growth Revenue: FMED's revenue (3.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: FMED's Return on Equity is forecast to be low in 3 years time (7.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y